Hematological Parameters as Prognostic Biomarkers in Patients with Cardiovascular Diseases

Current Cardiology Reviews
José Gildo de Moura Monteiro JúniorDário Celestino Sobral Filho

Abstract

Cardiovascular diseases are the major causes of preventable health loss from disease in the world and lead to functional disturbances including hematological parameters. The inflammatory and hypoxemic nature of cardiovascular diseases causes a stimulus in the bone marrow and, depending on the intensity of this stimulus, there is a release of immature cells or increase of other cells in the bloodstream. Therefore, their presence in the circulation is an important variable used to diagnose, stratify and predict diseases. In the last five decades, with the advent of automated counting of immature cells in the peripheral blood, the hemogram was transformed into a clinical tool of great importance in hospital surveillance for demonstrating this daily variability in the hematopoietic response according to the existing injury in the patient. Studies have shown that the presence of nucleated red blood cells and increases in mean platelet volume, immature granulocytes and neutrophil to lymphocyte ratio in the systemic circulation are independent prognostic biomarkers. This review article has as main objective to demonstrate the association of these hematological parameters to cardiovascular diseases, emphasizing their importance in clin...Continue Reading

References

Apr 12, 2001·American Journal of Physiology. Heart and Circulatory Physiology·R B AmiS Yedgar
Jun 7, 2007·Critical Care : the Official Journal of the Critical Care Forum·Axel StachonMichael Krieg
Jul 3, 2007·Journal of the American College of Cardiology·G Michael FelkerUNKNOWN CHARM Investigators
Jan 4, 2008·Circulation·Marcello TonelliUNKNOWN for the Cholesterol and Recurrent Events (CARE) Trial Investigators
Mar 5, 2008·Arquivos brasileiros de cardiologia·Ana Denise ZazulaJosé Rocha Faria Neto
Jun 14, 2008·American Journal of Clinical Pathology·Mauro Buttarello, Mario Plebani
Oct 15, 2010·Journal of Thrombosis and Haemostasis : JTH·J KlovaiteB G Nordestgaard
Oct 20, 2010·Journal of Thrombosis and Haemostasis : JTH·E L GroveS D Kristensen
Dec 2, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Sandra KuertAxel Stachon
Jan 18, 2011·Hematology·Andreas Greinacher, Kathleen Selleng
Jan 5, 2012·Clinical Hemorheology and Microcirculation·Irina A TikhomirovaSvetlana G Mikhailova
Jul 14, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hasan KayaMehmet Serdar Soydinç
Sep 15, 2012·Clinical Hemorheology and Microcirculation·Oguz K Baskurt, Herbert J Meiselman
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Jun 12, 2013·The Journal of Cell Biology·Kellie R Machlus, Joseph E Italiano
Dec 3, 2014·Journal of the American College of Cardiology·Homam IbrahimNeal S Kleiman
Feb 14, 2015·Clinics in Laboratory Medicine·Ralph Green, Sebastian Wachsmann-Hogiu
Feb 14, 2015·Clinics in Laboratory Medicine·Sue Ellen Verbrugge, Albert Huisman
Feb 14, 2015·Clinics in Laboratory Medicine·Thomas Pierre Lecompte, Michael Pierre Bernimoulin
Mar 31, 2015·Angiology·Monica VerdoiaUNKNOWN Novara Atherosclerosis Study Group (NAS)
Apr 10, 2015·Physiological Measurement·M PuertasP J Fabri
Dec 20, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Liang LiChao-Ke Tang
Dec 30, 2015·PloS One·José Gildo de Moura Monteiro JúniorDário Celestino Sobral Filho
Nov 4, 2016·The Korean Journal of Internal Medicine·Hilal Bektas UysalHulki Meltem Sönmez
Jun 22, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Sen LiuJian-Hua Zhou
Jan 21, 2017·Journal of Clinical Laboratory Analysis·Marzieh EmamianMajid Ghayour-Mobarhan
Nov 8, 2017·Disease Markers·Jan BudzianowskiJarosław Hiczkiewicz
Apr 19, 2018·PloS One·José Gildo de Moura Monteiro JúniorDário Celestino Sobral Filho
Jan 10, 2019·The New England Journal of Medicine·Daniel M MusherVicente F Corrales-Medina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.